| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
| World Community Grid Forums
|
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 1122
|
|
| Author |
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/215497.php
"Article Date: 03 Feb 2011 In The Majority Of AIDS Patients The Viral Load Is Reduced By Therapeutic AIDS Vaccine Designed By HIVACAT The therapeutic vaccines are a priority research line of the HIVACAT, the catalan programme for the development of therapeutic vaccines and prevention against the Human Immunodeficiency Virus (HIV). This type of therapeutic vaccine helps the patients who are carriers of the virus, combat infection and control the appearance of AIDS in the same way as with the current antiretroviral treatments. The final aim of the therapeutic vaccines will be to avoid a life long treatment with antiretroviral drugs. The research team 'Infectious Diseases and AIDS' led by Dr. Josep Maria Gastell from IDIBAPS - Hospital Clinic has developed using the brand HIVACAT, a model of the therapuetic vaccine based on the patient's own dendritic cells. This reduction in the viral load is still considered to be insuficient but it is the first therapeutic vaccine which has achieved a postive response in the majority of patients..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.eurekalert.org/pub_releases/2011-02/waeh-bbi020211.php
"Public release date: 3-Feb-2011 Boosting body's immune response may hold key to HIV cure Australian scientists have successfully cleared a HIV-like infection from mice by boosting the function of cells vital to the immune response. A team led by Dr Marc Pellegrini from the Walter and Eliza Hall Institute showed that a cell signaling hormone called interleukin-7 (IL-7) reinvigorates the immune response to chronic viral infection, allowing the host to completely clear virus. Their findings were released in today's edition of the journal Cell..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
It appears that IL-7 is the subject of ongoing research. The appended URL lists a number of different IL7 related trials involving HIV positive patients in the United States, Canada, France, Italy, Switzerland, South Africa, Spain, and the United Kingdom
http://www.cytheris.com/Clinical_Trials/hiv.php |
||
|
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
|
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
Confirmation that the mathematical modeling approach used by research projects such as Fight Against Aids @ Home may be the most effective method yet for finding new drug candidates against HIV.
http://www.eurekalert.org/pub_releases/2011-02/pues-mmh020711.php "Public release date: 7-Feb-2011 Math may help calculate way to find new drugs for HIV and other diseases Techique finds best drug candidates among millions of choices Using mathematical concepts, Princeton researchers have developed a method of discovering new drugs for a range of diseases by calculating which physical properties of biological molecules may predict their effectiveness as medicines. The technique already has identified several potential new drugs that were shown to be effective for fighting strains of HIV by researchers at Johns Hopkins University. "The power of this is that it's a general method," said Princeton chemical and biological engineering professor Christodoulos Floudas, who led the research team. "It has proven successful in finding potential peptides to fight HIV, but it should also be effective in searching for drugs for other diseases." Floudas, the Stephen C. Macaleer '63 Professor in Engineering and Applied Science, and Princeton engineering doctoral student Meghan Bellows-Peterson collaborated on the study with researchers at the Johns Hopkins University School of Medicine. Their findings were reported in the Nov. 17, 2010, issue of Biophysical Journal. The researchers' technique combines concepts from optimization theory, a field of mathematics that focuses on calculating the best option among a number of choices, with those of computational biology, which combines mathematics, statistics and computer science for biology research. In the case of HIV, the challenge for the Princeton team was to find peptides -- the small chains of biologically active amino acids that are the basic building blocks of proteins -- that could stop the virus from infecting human cells..." |
||
|
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
National Black AIDS Awareness Day
61 percent of HIV/AIDS cases are blacks Day month , year etc.., all inside each this posts |
||
|
|
Papa3
Senior Cruncher Joined: Apr 23, 2006 Post Count: 360 Status: Offline Project Badges:
|
http://www.sciencedaily.com/releases/2011/01/110110154645.htm
New Method Takes Snapshots of Proteins as They Fold ScienceDaily (Jan. 10, 2011) — Scientists have invented a way to 'watch' proteins fold -- in less than thousandths of a second -- into the elaborate twisted shapes that determine their function. [...] the scientists demonstrated that the new technique can follow folding and unfolding on a submillisecond time scale. [...] this proof-of-principle experiment stands at the end of a long line of elegant experiments of a similar type, called pump-probe experiments. Other techniques probe the change in protein structure by monitoring the absorption or emission of light--or a similar physical effect. They can provide only global information, such as the rate constant of a folding reaction. "Because we use a chemical rather than a physical probe, we can see what's going on in much greater detail," says Gross. "We can say which part of the structure closes first, which second, and so on." [...] Jiawei Chen, Don L. Rempel, Michael L. Gross. Temperature Jump and Fast Photochemical Oxidation Probe Submillisecond Protein Folding. Journal of the American Chemical Society, 2010; 132 (44): 15502 DOI: 10.1021/ja106518d |
||
|
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
|
||
|
|
Papa3
Senior Cruncher Joined: Apr 23, 2006 Post Count: 360 Status: Offline Project Badges:
|
http://arstechnica.com/science/news/2011/02/x...us-as-it-vaporizes-it.ars
X-ray laser finds structure of a single virus as it vaporizes it In two Letters in Nature, scientists are reporting that they have been able to reconstruct the structures of biological molecules using femtosecond X-ray pulses. In the first Letter, they imaged nano-crystals of the photosystem I protein, part of the photosynthetic machinery. In the second, they were able to image individual single mimiviruses, part of a family of giant viruses. We seem to be well on the way to single molecule structural imaging. [...] higher energy x-rays and shorter bursts are expected to increase resolution and decrease the size of the sample particles. Plans are already in the works for x-ray lasers 105 times brighter but with pulses lasting less than 10fs. |
||
|
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Women with HIV are at higher risk of developing cervical cancer as a result of infection with human papillomavirus.
This clinical review examines different methods of screening to identify the cervical abnormalities that may lead to cervical cancer if not treated. It also examines challenges in screening, diagnosis and treatment in resource-limited settings, and includes a case study of a 'see and treat' cervical screening programme in Zambia. The clinical review examines the epidemiology of cervical cancer in women living with HIV, and the outcomes of treatment. It also discusses palliative care for women with cervical cancer. This edition of HATIP was kindly supported by the Diana, Princess of Wales Memorial Fund. About HATIP HATIP is a regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings. HATIP is published by NAM, a community-based organisation and registered charity that supports people living and working with HIV by providing accurate, impartial, and up-to-date information about HIV/AIDS. We believe that, wherever you are in the world, accessing accurate information is vital in the global management of HIV. The newsletter is edited by Theo Smart (Cape Town) and Keith Alcorn, NAM’s Senior Editor (London). For further information please visit http://www.aidsmap.com/hatip Its publication is supported by the UK government’s Department for International Development (DfID), the Stop TB department of the World Health Organization and the Diana, Princess of Wales Memorial Fund. |
||
|
|
|